Minimal residual disease–driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL
| Autor: | Scarfò, Lydia, Heltai, Silvia, Albi, Elisa, Scarano, Eloise, Schiattone, Luana, Farina, Lucia, Moia, Riccardo, Deodato, Marina, Ferrario, Andrea, Motta, Marina, Reda, Gianluigi, Sancetta, Rosaria, Coscia, Marta, Rivela, Paolo, Laurenti, Luca, Varettoni, Marzia, Perotta, Eleonora, Capasso, Antonella, Ranghetti, Pamela, Colia, Maria, Ghia, Paolo ∗ |
|---|---|
| Zdroj: | In Blood 1 December 2022 140(22):2348-2357 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|